Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:48 AM
Ignite Modification Date:
2025-12-25 @ 3:48 AM
NCT ID:
NCT01146002
Eligibility Criteria:
Inclusion Criteria: Diagnosis of ADHD-inattentive or combined type.
Exclusion Criteria:
* Intelligence (IQ) below 85 as determined by formal testing.
* Identified or suspected genetic syndromes.
* Autism or other pervasive developmental disorders.
* Psychiatric disorders other than ADHD and oppositional defiant disorder.
* Heart, liver or renal disease.
* Cancer.
* Epilepsy or non-febrile seizure history.
* Cardiac arrhythmia, bradycardia, or syncope.
* Any other condition considered to be potentially exacerbated or endangered by treatment with an alpha-2 agonist drug.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
6 Years
Maximum Age:
12 Years
Study:
NCT01146002
Study Brief:
Protocol Section:
NCT01146002